Global Glipizide Market 2023-2030

    In Stock

    Coming Soon 




    Glipizide, sold under the brand name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type Two diabetes. It is used together with a diabetic diet and exercise. It is not indicated for use by itself in type one diabetes. It is taken by mouth. Effects generally begin within half an hour and can last for up to a day.


    Common side effects include nausea, diarrhea, low blood sugar, and headache. Other side effects include sleepiness, skin rash, and shakiness. The dose may need to be adjusted in those with liver or kidney disease. Use during pregnancy or breastfeeding is not recommended. It works by stimulating the pancreas to release insulin and increases tissue sensitivity to insulin.


    Glipizide was approved for medical use in the United States in the late nintey . It is available as a generic medication. In previous year, it was the top most commonly prescribed medication in the United States, with more than thirteen million prescriptions.



    infographic: Glipizide Market , Glipizide Market Size, Glipizide Market Trends, Glipizide Market Forecast, Glipizide Market Risks, Glipizide Market Report, Glipizide Market Share.


    The Global Glipizide Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Apollo Pharma Glipizide Glipizide sensitizes the beta cells of pancreatic islets of Langerhans insulin response, meaning that more insulin is released in response to glucose than would be without glipizide ingestion.


    Glipizide acts by partially blocking potassium channels among beta cells of pancreatic islets of Langerhans. By blocking potassium channels, the cell depolarizes, which results in the opening of voltage-gated calcium channels. The resulting calcium influx encourages insulin release from beta cells.


    GLIPIZIDE belongs to the group of antidiabetic medicines called ‘sulfonylureas’ used to treat type-2 diabetes mellitus. GLIPIZIDE is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. GLIPIZIDE works by increasing insulin production by stimulating insulin secretion from the beta cells of the pancreas, thereby reducing high blood glucose (sugar) levels. 


    GLIPIZIDE is not effective in people with type 1 diabetes or for treating serious hyperglycemia (high blood glucose levels). Consult your doctor before taking GLIPIZIDE if you are pregnant or breastfeeding.


    GLIPIZIDE is not recommended for children. Avoid alcohol consumption while taking GLIPIZIDE as it might increase side effects. GLIPIZIDE may cause dizziness and drowsiness, so drive only if you are alert. Inform your doctor about all the medications you are taking and your health condition to rule out any unpleasant side effects.




    1. How many Glipizide are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Glipizide and key vendor selection criteria
    3. Where is the Glipizide manufactured? What is the average margin per unit?
    4. Market share of Global Glipizide market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Glipizide in-house
    6. key predictions for next 5 years in Global Glipizide market
    7. Average B-2-B Glipizide market price in all segments
    8. Latest trends in Glipizide market, by every market segment
    9. The market size (both volume and value) of the Glipizide market in 2023-2030 and every year in between?
    10. Production breakup of Glipizide market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop